Sarepta licenses five LGMD gene therapy candidates from Myonexus; has option to buy company
- Gene Therapy, Cell Therapy
- Large Molecule
- Drug Delivery
- R+D and Marketing-Licensing
- Intra-Biotech Deal
- Includes M&A Option
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.